Page last updated: 2024-10-28

hydralazine and Epidermolysis Bullosa

hydralazine has been researched along with Epidermolysis Bullosa in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Epidermolysis Bullosa: Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hayashi, K1
Shimokawa, T1
Yamagata, M1
Yoneda, K1

Other Studies

1 other study available for hydralazine and Epidermolysis Bullosa

ArticleYear
Inhibition of α
    Journal of pharmacological sciences, 2021, Volume: 145, Issue:1

    Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blister; Disease Models, Animal; Disease Progressi

2021